#novartis
Related Stories (17)
US FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026Novartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026Legend Biotech taps Novartis veteran Zhang as CEO - reuters.com
Legend Biotech taps Novartis veteran Zhang as CEO reuters.com
September 15, 2026EXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks - Reuters
EXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks Reuters
September 10, 2026Novartis cholesterol setback tests hopes for emerging heart disease drugs - Reuters
Novartis cholesterol setback tests hopes for emerging heart disease drugs Reuters
September 7, 2026Novartis, Ionis' experimental heart drug misses key goal in closely watched trial - Reuters
Novartis, Ionis' experimental heart drug misses key goal in closely watched trial Reuters
September 4, 2026Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology - Reuters
Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology Reuters
September 2, 2026Novartis MS pill beats older drug in trials, boosts pipeline hopes - Reuters
Novartis MS pill beats older drug in trials, boosts pipeline hopes Reuters
September 1, 2026Novartis pauses autoimmune cell therapy studies after deaths, WSJ reports - Reuters
Novartis pauses autoimmune cell therapy studies after deaths, WSJ reports Reuters
September 1, 2026Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case - Reuters
Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case Reuters
August 5, 2026South African court grants Novo Nordisk petition to block Ozempic copies - Reuters
South African court grants Novo Nordisk petition to block Ozempic copies Reuters
June 22, 2026Swiss pharma hub Basel frets over population cap threat - Reuters
Swiss pharma hub Basel frets over population cap threat Reuters
June 12, 2026Novartis misses quarterly sales, profit estimates as Entresto generics hit growth - Reuters
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth Reuters
April 28, 2026Henrietta Lacks: Family of woman whose cells were 'stolen' settles second lawsuit
Novartis is the second drug company to settle a lawsuit brought by the family of a woman whose cells have enabled huge advances in science.
February 28, 2026Trump meets Novartis CEO, says drugmaker building 11 US plants - Reuters
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQWkRNOGVDMjdOeVNCcTZaWXAyQ1Jld0RoTnZYR19TUTMwQXpqTUdtZHVxUWR6blNTbG9hTFdnV0pjRGtWVWl6aU9CWjM4THZYN0tMZHBMd0w4ajFDT0NjbkwybjJXeFFObUZSMmZ0TTdLWVlId0oxLUE2OFNkUUFvaUJwel96U0VQZjJJbW5EcUhpZHpDRmI5N09FOEw3a0FsbmsxcGNla3NSdw?oc=5" target="_blank">Trump meets Novartis CEO, says drugmaker building 11 US plants</a> <font color="#6f6f6f">Reuters</font>
February 20, 2026Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20% - Reuters
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOLXJ6YWlYcmIyRDdRMjQ0SjhrNTFpQi0ySm5TRnFQdnhWZEY2MXpHUXY3RXM4b185Y01EalZDT3duNjNQNTVqcnMxRUJMaFUxVkNBZ1JpSmNYNlBLQWlKRmdsOS1zS0FmZVRpQW44MnlvUl9CekxOREZleUNLbFlZUmItZF90V2lyWU0xa0doZmNQWDg1dXZiOWJEYWFkQmgwZW1EQ2FxMF94c0xEQlZzLTJJNUFEYmtuV3c?oc=5" target="_blank">Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20%</a> <font color="#6f6f6f">Reuters</font>
February 20, 2026Related Pages (20)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Swiss pharma hub Basel frets over population cap threat
Published on 06/12/2026 at 05:01 am BST - Modified on 06/12/2026 at 05:07 am BST BASEL, Switzerland, June 12 (Reuters) - For decades, economic growth in
Novartis shares fall after weak Q1 hit by Entresto competition
AI Sentiment: 18/100 Bearish This score is generated through AI-driven analysis of the article's content. powered by Buy NVS. The stock is down on a predictable, already-announced Entresto patent
Novartis Q1 profit down on US generic erosion
Swiss drugmaker Novartis reported first-quarter core operating profit below market expectations on Tuesday, as generic competition for its top-selling heart drug Entresto weighed on sales. Quarterly
Novartis misses Q1 profit estimates on steep generic erosion
Group operating income is down by 12% at US$4.9 billion, below analyst expectations of US$5.1 billion Share [BASEL] Swiss drugmaker Novartis reported first-quarter core operating profit below market
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth
Take advantage of our newsletter subscription and stay informed on the go!
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and
Novartis settles with woman's estate over use of her "stolen" cells to advance medicine
February 27, 2026 / 5:34 AM EST / AP Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were take
Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine
This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. (Georgios Kefalas/Keystone via AP, File) Attorney Ben Crump,